Abstract
PIPAC is an innovative drug delivery technique for the treatment of peritoneal metastases. Its application gained popularity over the past years. Prospective clinical trials are being conducted to determine efficacy and safety. At this moment, there remain many challenges to overcome before PIPAC can be widely adopted in clinical practice.
- Received December 4, 2020.
- Revision received January 8, 2021.
- Accepted January 13, 2021.
- Copyright ©2021, American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
This OnlineFirst version was published on January 20, 2021
doi: 10.1158/1078-0432.CCR-20-4342
Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof
Jump to section
Advertisement